Evidence map›Paper›PMID 39786380›Full record

ArticleBlood advances2025

Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma.

Samer Al Hadidi, Obada Ababneh, Carolina Schinke, Sharmilan Thanendrarajan, Clyde Bailey, Robert Smith, Susan Panozzo, Daisy Alapat, Guido Tricot, John Shaughnessy and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Samer Al HadidiMyeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR.ORCID 0000-0003-4297-8042
Obada AbabnehFaculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.ORCID 0000-0001-7487-9095
Carolina SchinkeMyeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR.ORCID 0000-0002-2699-1741
Sharmilan ThanendrarajanMyeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR.
Clyde BaileyMyeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR.
Robert SmithMyeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR.
Susan PanozzoMyeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR.
Daisy AlapatDepartment of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR.
Guido TricotMyeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR.ORCID 0000-0002-3111-9739
John ShaughnessyMyeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR.
Fenghuang ZhanMyeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR.ORCID 0000-0001-5417-2973
Jeffrey SawyerMyeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR.
Eric R SiegelDepartment of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR.ORCID 0000-0001-9824-6612
Bart BarlogieMyeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR.
Frits van RheeMyeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR.
Maurizio ZangariMyeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR.

Funding

Tumor Cell-Microenvironment Interactions in the Molecular Pathogenesis of MultiplP01CA055819 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI BELLAMY, WILLIAM T · 1993 to 2013
$49.7M
NCI NIH HHS P01 CA055819
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39786380
PMCPMC11934280

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.